The adiponectin/carnitine palmitoyltransferase 1 A- (APN/CPT1A-) mediated fatty acid metabolism has been shown to confer partial protection against IPF through the activation of autophagy, offering novel avenues for IPF treatment [29]. Here, ADIPOQ is linked to idiopathic pulmonary fibrosis.